(EQNR) Equinor ASA - Ratings and Ratios
Oil, Gas, Wind, Hydrogen, Solar
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.64% |
| Yield on Cost 5y | 15.17% |
| Yield CAGR 5y | 41.98% |
| Payout Consistency | 91.6% |
| Payout Ratio | 67.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 28.5% |
| Value at Risk 5%th | 47.4% |
| Relative Tail Risk | 1.07% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -0.45 |
| CAGR/Max DD | -0.23 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.392 |
| Beta | 0.468 |
| Beta Downside | 0.852 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.52% |
| Mean DD | 16.05% |
| Median DD | 16.26% |
Description: EQNR Equinor ASA December 02, 2025
Equinor ASA (NYSE:EQNR) is a Norway-based integrated energy company that explores, produces, transports, refines, and markets petroleum and other energy forms across Norway and globally.
The firm operates through six segments: Exploration & Production Norway, Exploration & Production International, Exploration & Production USA, Marketing, Midstream & Processing, Renewables, and Other activities.
Key recent metrics (2023-2024) include ≈ 2.2 million barrels of oil equivalent per day of net production, a ≈ $12 billion upstream capital-expenditure plan, and a ≈ 15 % reduction in carbon intensity per barrel versus 2020, reflecting its accelerated push into offshore wind (≈ 2 GW under development) and green hydrogen projects.
Equinor’s earnings are highly sensitive to global oil price trends, OPEC+ output decisions, and the pace of LNG demand growth in Europe-factors that together drive its cash-flow volatility and investment horizon.
For a deeper, data-driven assessment of Equinor’s valuation dynamics, you may find ValueRay’s analytical toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (5.73b TTM) > 0 and > 6% of Revenue (6% = 6.42b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -1.68pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.22% (prev 15.90%; Δ -8.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.15 (>3.0%) and CFO 20.36b > Net Income 5.73b (YES >=105%, WARN >=100%) |
| Net Debt (22.84b) to EBITDA (40.34b) ratio: 0.57 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.63b) change vs 12m ago -4.99% (target <= -2.0% for YES) |
| Gross Margin 37.59% (prev 41.98%; Δ -4.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 79.03% (prev 77.57%; Δ 1.46pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 19.70 (EBITDA TTM 40.34b / Interest Expense TTM 1.44b) >= 6 (WARN >= 3) |
Altman Z'' 3.38
| (A) 0.06 = (Total Current Assets 41.45b - Total Current Liabilities 33.72b) / Total Assets 135.85b |
| (B) 0.35 = Retained Earnings (Balance) 47.94b / Total Assets 135.85b |
| (C) 0.21 = EBIT TTM 28.42b / Avg Total Assets 135.48b |
| (D) 0.43 = Book Value of Equity 40.52b / Total Liabilities 95.25b |
| Total Rating: 3.38 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.51
| 1. Piotroski 6.0pt |
| 2. FCF Yield 10.31% |
| 3. FCF Margin 6.38% |
| 4. Debt/Equity 0.76 |
| 5. Debt/Ebitda 0.57 |
| 6. ROIC - WACC (= 30.61)% |
| 7. RoE 13.42% |
| 8. Rev. Trend -68.03% |
| 9. EPS Trend -81.57% |
What is the price of EQNR shares?
Over the past week, the price has changed by -1.04%, over one month by -1.93%, over three months by -4.05% and over the past year by +10.43%.
Is EQNR a buy, sell or hold?
- Strong Buy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the EQNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 23.8 | 4.1% |
| Analysts Target Price | 23.8 | 4.1% |
| ValueRay Target Price | 24.1 | 5.8% |
EQNR Fundamental Data Overview December 21, 2025
P/E Trailing = 10.7383
P/E Forward = 8.3682
P/S = 0.5388
P/B = 1.428
P/EG = 3.5734
Beta = -0.297
Revenue TTM = 107.07b USD
EBIT TTM = 28.42b USD
EBITDA TTM = 40.34b USD
Long Term Debt = 22.90b USD (from longTermDebt, last quarter)
Short Term Debt = 5.88b USD (from shortTermDebt, last quarter)
Debt = 30.95b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 22.84b USD (from netDebt column, last quarter)
Enterprise Value = 66.25b USD (57.68b + Debt 30.95b - CCE 22.39b)
Interest Coverage Ratio = 19.70 (Ebit TTM 28.42b / Interest Expense TTM 1.44b)
FCF Yield = 10.31% (FCF TTM 6.83b / Enterprise Value 66.25b)
FCF Margin = 6.38% (FCF TTM 6.83b / Revenue TTM 107.07b)
Net Margin = 5.35% (Net Income TTM 5.73b / Revenue TTM 107.07b)
Gross Margin = 37.59% ((Revenue TTM 107.07b - Cost of Revenue TTM 66.82b) / Revenue TTM)
Gross Margin QoQ = 33.84% (prev 35.69%)
Tobins Q-Ratio = 0.49 (Enterprise Value 66.25b / Total Assets 135.85b)
Interest Expense / Debt = 1.18% (Interest Expense 366.0m / Debt 30.95b)
Taxrate = 104.4% (out of range, set to none) (4.87b / 4.67b)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.23 (Total Current Assets 41.45b / Total Current Liabilities 33.72b)
Debt / Equity = 0.76 (Debt 30.95b / totalStockholderEquity, last quarter 40.52b)
Debt / EBITDA = 0.57 (Net Debt 22.84b / EBITDA 40.34b)
Debt / FCF = 3.35 (Net Debt 22.84b / FCF TTM 6.83b)
Total Stockholder Equity = 42.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.22% (Net Income 5.73b / Total Assets 135.85b)
RoE = 13.42% (Net Income TTM 5.73b / Total Stockholder Equity 42.65b)
RoCE = 43.36% (EBIT 28.42b / Capital Employed (Equity 42.65b + L.T.Debt 22.90b))
RoIC = 35.65% (EBIT 28.42b / (Assets 135.85b - Curr.Liab 33.72b - Cash 22.39b))
WACC = 5.04% (E(57.68b)/V(88.64b) * Re(7.74%) + (debt cost/tax rate unavailable))
Discount Rate = 7.74% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -5.77%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈7.72b ; Y1≈5.07b ; Y5≈2.32b
Fair Price DCF = 18.18 (DCF Value 45.57b / Shares Outstanding 2.51b; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -81.57 | EPS CAGR: -28.47% | SUE: -2.15 | # QB: 0
Revenue Correlation: -68.03 | Revenue CAGR: -5.47% | SUE: 0.09 | # QB: 0
EPS next Year (2026-12-31): EPS=3.02 | Chg30d=+0.550 | Revisions Net=-1 | Growth EPS=+1.3% | Growth Revenue=-5.5%
Additional Sources for EQNR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle